Original Source(s)
Related Content
This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement
A first-in-human study reduces stem-cell collection and manufacturing times, Bristol Myers ends its Breyanzi agreement with Cellares, and two approaches strengthen CAR T-cell activity against solid tumors
August 31, 2026
-
5 min